Preview Mode Links will not work in preview mode

 

Welcome to the Empowered Patient Podcast with Karen Jagoda.  This show is a window into the latest innovations in applying generative AI, novel therapeutics and vaccines, and the changing dynamics in the medical and healthcare environment. One focus is on how providers, pharmaceutical companies, and payers are empowering patients.  In addition, conversations are often about how providers, care facilities, pharmaceutical companies, and payers are being empowered by technology to improve patient outcomes and reduce friction across the healthcare landscape.

Popular Topics

  • Virtual and digital health
  • Use of AI, ML, and LLM in healthcare and drug discovery, development, trials
  • Value-based healthcare 
  • Precision and stratified medicine
  • Integration of digital technology into existing workflow and procedures 
  • Next-generation immuno, cell, and gene therapies
  • Vaccines
  • Biomarkers, sequencing, and imaging
  • Rare diseases
  • MedTech and medical devices
  • Clinical trials
  • Addressing Social Determinants of Health
  • Treating chronic conditions like obesity and pain
  • Clinician and staff burnout

The audience includes life science leaders, researchers, medical professionals, patient advocates, digital health entrepreneurs, patients, caregivers, healthcare solution providers, students, journalists, and investors. 

 

Check out our new EmpoweredPatient.Solutions site where you can quickly search all of the Empowered Patient Podcast interviews by any word or phrase to identify useful resources, potential partners, and insights about the life sciences landscape.

Empowered Patient Solutions

Sep 20, 2023

Dr. Bill Kerr, Co-Founder and CEO of Avalon Healthcare Solutions, sheds light on the value of genetic data and is focused on getting the science of gene sequencing better understood. Genetic testing can identify opportunities for treatment and specific mutations that can lead to a more precise therapy. With the abundance of genetic tests available, interpreting the results correctly is the challenge.

Bill elaborates, "Our job is to get the science of lab testing adopted in the industry. We have done that by working with health plans that have to adopt coverage for the testing, to be paid for the labs that perform the testing, and then the physician experts who either define the testing when it's useful or who are ordering the testing. We live in an ecosystem where we work with all those parties to ensure that good genetic testing is adopted, that the results are understood, and that they are acted upon appropriately."

"The real issue is understanding when a test can be useful to a patient and a doctor. Just because we can sequence DNA doesn't mean we understand what it means or what to do about it. I would suggest to you that one of the reasons we have heard the phrase precision medicine for so long but have not seen as much of that get adopted is we haven't understood the link between what we see in the DNA and what we know to do about it. I'll give you a couple of examples."

"One, cancer. Cancer has been an area where we have, for some time, understood that certain genetic predispositions or even mutations can drive cancer or suggest that cancer could be worse. We have just recently had therapies that target those mutations. Now, we've got several great therapies that are tied to that. Previously, just doing the analysis may have had no real benefit to the patient or maybe later had some prognostic capability, but now actually has therapeutic relevance. That's been very important." 

#AvalonHealthcare #AvalonHCS #GeneticTesting #GeneticTests #LabTests #LabTesting #ClinicalTesting #ClinicalTests #MedicalTests

avalonhcs.com

Listen to the podcast here

Avalon